Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × apatinib × Clear all

NCT05095636 2021-10-27

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT03913182 2020-02-05

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Recurrence

NCT04180007 2019-11-27

APT-01

Phase 2 Unknown

Neoplasm Metastasis, Thyroid Diseases